It is engaged in the development, commercialization and licensing of recombinant adeno-associated virus gene therapy. Regenxbio Inc has a market ...
https://www.google.com/url?rct=j&sa=t&url=https://finance.yahoo.com/news/regenxbio-inc-rgnx-president-ceo-221505824.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNFW-gmVBkORfk9gQ9Td4sXbNg2wCA
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.